Genmab A/S

GMAB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$8$6$7$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$1
Stock-Based Comp.$1$1$0$0
Change in WC-$2$1-$2-$1
Other Non-Cash$0-$1-$2-$1
Operating Cash Flow$8$7$4$2
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions-$12$0$2$1
Inv. Purchases-$9-$11-$10-$16
Inv. Sales/Matur.$11$10$7$15
Other Inv. Act.-$0-$0-$2-$1
Investing Cash Flow-$10-$1-$3-$1
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.-$4-$1-$1-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$4-$1-$1-$0
Forex Effect$1-$1$1$1
Net Chg. in Cash-$5$5$1$2
Supplemental Information
Beg. Cash$15$10$9$7
End Cash$10$15$10$9
Free Cash Flow$8$7$4$2
Genmab A/S (GMAB) Financial Statements & Key Stats | AlphaPilot